Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
SCOUT-Assisted Review Workflow
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease (CHD)
1 trial -
SGLT2 inhibitor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Kidney Transplantation
1 trial -
SHAPE
The First People's Hospital of Lianyungang
Liver Cirrhosis
1 trial -
SLE group
The First People's Hospital of Lianyungang
Lupus Nephritis
1 trial -
SPECT/CT imaging with 99mTc-P137 nuclide probe
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
SSRI
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
SSRIs
The First People's Hospital of Lianyungang
Major Depressive Disorder
2 trials -
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder
1 trial -
Salvianolic Acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
Sarcosine Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Parkinson's Disease With Dementia
1 trial -
Screening only
Hospital Authority, Hong Kong
Panic Attacks and Disorders
1 trial -
Secukinumab 300 MG; Tofacitinib 11mg
The First People's Hospital of Lianyungang
Hidradenitis Suppurativa
1 trial -
Selective Serotonin Reuptake Inhibitors (SSRIs)
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Senl_B19 autologous CAR-T (S1904) treatment
The First People's Hospital of Lianyungang
Relapsed Adult ALL
1 trial -
Sertraline plus placebo of JWXYJN
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depressive Disorder
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Aged
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Anesthesia, General
1 trial -
Shenbai Granules
The First People's Hospital of Lianyungang
Colorectal Adenoma
1 trial -
Sheng-Yu-Tang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Leukemia
1 trial -
Short course palliative radiation.
Hospital Authority, Hong Kong
Cervical Cancer
1 trial -
Sildenafil 100 MG
The First People's Hospital of Lianyungang
Central Venous Pressure
1 trial -
Simvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hyperlipidemias
1 trial -
Single dose of 2L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Health Behavior
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources